Frederick, MD, United States of America

C Andrew Stewart

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: C Andrew Stewart: Innovator in Chimeric Antigen Receptors

Introduction

C Andrew Stewart is a prominent inventor based in Frederick, MD (US), known for his significant contributions to the field of immunotherapy. He holds a total of four patents, showcasing his innovative approach to cancer treatment through advanced technologies.

Latest Patents

Among his latest patents are the Anti-BCMA chimeric antigen receptors. These chimeric antigen receptors (CARs) are designed to target BCMA, exhibiting enhanced properties such as improved binding to BCMA and increased efficacy in killing BCMA-expressing cancer cells. The applications of these CARs extend to immune cells, including T cells, and involve various compositions and methods for their use.

Career Highlights

C Andrew Stewart has worked with notable organizations, including Cartesian Therapeutics, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has been pivotal in advancing research and development in the field of immunotherapy.

Collaborations

He has collaborated with esteemed colleagues such as Yi Zhang and Metin Kurtoglu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

C Andrew Stewart's work in developing chimeric antigen receptors represents a significant advancement in cancer treatment. His innovative spirit and dedication to research continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…